Human Health and Potential (HHP)

Researchers have discovered a molecular pathway in colorectal cancer cells that leads to uncontrolled division, creating an avenue for more targeted therapies.

By analysing heart cells, a new machine learning algorithm could help predict arrhythmia risk before symptoms appear.

Booster shots with COVID-19 mRNA outperformed inactivated virus by eliciting stronger antibody responses to the Omicron variant.

A new microfluidic liver-on-a-chip platform offers drug developers a stable, scalable and sensitive testing ground for much-needed treatments in fatty liver disease.

Drug-resistant malarial parasites form flower-like structures to shield themselves from attack by antimalarial drugs and the immune system.

Researchers develop machine learning models for accurately diagnosing an inflammatory skin condition.

A new diagnostic innovation powered by artificial intelligence could empower surgeons to make more accurate and effective clinical decisions for colon cancer patients.

A new computational tool gives scientists a 3D view of the gene expression landscape in tissues to better track disease progression and design targeted drugs.

Advanced biosensors integrated into dressings capture molecular information to monitor whether wounds are healing.

Molecular simulations uncover a new druggable pocket in SARS-CoV-2’s spike protein which could hold the key to blocking COVID-19 infections.

A*STAR scientists decipher how a stem cell-based treatment stops the uncontrolled inflammation associated with severe COVID-19 cases.

Using a new genome analysis technology, A*STAR scientists discover never-before-seen immune responses in tuberculosis infections.